| ［1］ |
欧阳飞, 房慧, 曾慧, 等. 玫瑰痤疮的发病机制［J］. 临床医药文献电子杂志, 2020,7（20）:190,193.
|
| ［2］ |
孙菲菲, 林燕, 刘华绪， 等.玫瑰痤疮难治性红斑治疗进展［J］. 中国麻风皮肤病杂志, 2020,36（9）:571⁃576. doi:10.12144/zgmfskin202009571.
|
| ［3］ |
Sousa⁃Valente J, Brain SD. A historical perspective on the role of sensory nerves in neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:229⁃236. doi: 10.1007/s00281⁃018⁃0673⁃1.
|
| ［4］ |
邱晓, 华艳, 白玉龙. 神经源性炎症在复杂性区域疼痛综合征发病中的作用机制研究进展［J］. 中国临床神经科学, 2019,27（3）:329⁃334,346.
|
| ［5］ |
Choi JE, Di Nardo A. Skin neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:249⁃259. doi: 10.1007/s00281⁃018⁃0675⁃z.
|
| ［6］ |
Kruger L, Perl ER, Sedivec MJ. Fine structure of myelinated mechanical nociceptor endings in cat hairy skin［J］. J Comp Neurol, 1981,198（1）:137⁃154. doi: 10.1002/cne.901980112.
|
| ［7］ |
McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency［J］. Arch Neurol, 1998,55（12）:1513⁃1520. doi: 10.1001/archneur.55. 12.1513.
|
| ［8］ |
Huet F, Misery L. Sensitive skin is a neuropathic disorder［J］. Exp Dermatol, 2019,28（12）:1470⁃1473. doi: 10.1111/exd.13991.
|
| ［9］ |
Sulk M, Seeliger S, Aubert J, et al. Distribution and expression of non⁃neuronal transient receptor potential （TRPV） ion channels in rosacea［J］. J Invest Dermatol, 2012,132（4）:1253⁃1262. doi: 10.1038/jid.2011.424.
|
| ［10］ |
Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:53⁃62. doi: 10.1038/jidsymp.2011.6.
|
| ［11］ |
Lonne⁃Rahm S, Nordlind K, Edström DW, et al. Laser treatment of rosacea: a pathoetiological study［J］. Arch Dermatol, 2004,140（11）:1345⁃1349. doi: 10.1001/archderm.140.11.1345.
|
| ［12］ |
张华雄, 李吉. 玫瑰痤疮先天免疫及周围神经相关致病机理研究进展［J］. 医学信息, 2019,32（8）:53⁃57. doi: 10.3969/j.issn.1006⁃1959.2019.08.017.
|
| ［13］ |
Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation［J］. J Investig Dermatol Symp Proc, 2011,15（1）:33⁃39. doi: 10.1038/jidsymp.2011.8.
|
| ［14］ |
Russell FA, King R, Smillie SJ, et al. Calcitonin gene⁃related peptide: physiology and pathophysiology［J］. Physiol Rev, 2014,94（4）:1099⁃1142. doi: 10.1152/physrev.00034.2013.
|
| ［15］ |
Helfrich YR, Maier LE, Cui Y, et al. Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging［J］. JAMA Dermatol, 2015,151（8）:825⁃836. doi: 10.1001/jamadermatol.2014.4728.
|
| ［16］ |
Baylie RL, Brayden JE. TRPV channels and vascular function［J］. Acta Physiol （Oxf）, 2011,203（1）:99⁃116. doi: 10.1111/j.1748⁃1716.2010.02217.x.
|
| ［17］ |
Samanta A, Hughes T, Moiseenkova⁃Bell VY. Transient receptor potential （TRP） channels［J］. Subcell Biochem, 2018,87:141⁃165. doi: 10.1007/978⁃981⁃10⁃7757⁃9_6.
|
| ［18］ |
王莲, 张自辉, 蒋献. 玫瑰痤疮发病机制的研究进展［J］. 实用皮肤病学杂志, 2019,12（3）:171⁃174. doi: 10.11786/sypfbxzz. 1674⁃1293.20190312.
|
| ［19］ |
Moore C, Cevikbas F, Pasolli HA, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin⁃1 signaling［J］. Proc Natl Acad Sci U S A, 2013,110（34）:E3225⁃3234. doi: 10. 1073/pnas.1312933110.
|
| ［20］ |
陈晓曦. 肥大细胞特异性受体介导神经源性炎症和疼痛［J］. 中国疼痛医学杂志, 2019,25（3）:171. doi: 10.3969/j.issn.1006⁃9852.2019.03.006.
|
| ［21］ |
Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin⁃initiated skin inflammation in rosacea［J］. J Invest Dermatol, 2014,134（11）:2728⁃2736. doi: 10.1038/jid.2014.222.
|
| ［22］ |
Mascarenhas NL, Wang Z, Chang YL, et al. TRPV4 mediates mast cell activation in cathelicidin⁃induced rosacea inflammation［J］. J Invest Dermatol, 2017,137（4）:972⁃975. doi: 10.1016/j.jid.2016.10.046.
|
| ［23］ |
李明凤, 蒋娟. 玫瑰痤疮发病的免疫机制研究进展［J］. 中国麻风皮肤病杂志, 2017,33（11）:690⁃692,697.
|
| ［24］ |
Dayan SH, Pritzker RN, Arkins JP. A new treatment regimen for rosacea: onabotulinumtoxinA［J］. J Drugs Dermatol, 2012,11（12）:e76⁃e79.
|
| ［25］ |
Bharti J, Sonthalia S, Jakhar D. Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea［J］. J Am Acad Dermatol, 2018,S0190⁃9622（18）30808⁃9. doi: 10. 1016/j.jaad.2018. 05.014.
|
| ［26］ |
Kim MJ, Kim JH, Cheon HI, et al. Assessment of skin physiology change and safety after intradermal injections with botulinum toxin: a randomized, double⁃blind, placebo⁃controlled, split⁃face pilot study in rosacea patients with facial erythema［J］. Dermatol Surg, 2019,45（9）:1155⁃1162. doi: 10.1097/DSS.000000 000000 1819.
|
| ［27］ |
Park KY, Hyun MY, Jeong SY, et al. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea［J］. Dermatology, 2015, 230（4）:299⁃301. doi: 10.1159/000368773.
|
| ［28］ |
黄智, 连亚军, 武守义. 肉毒毒素抗癫痫作用的研究进展［J］. 中国实用神经疾病杂志, 2018,21（3）:336⁃339. doi: 10.12083/SYSJ.2018.03.086.
|
| ［29］ |
Choi JE,Werbel T, Wang Z, et al. Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci, 2019,93（1）:58⁃64. doi: 10.1016/j.jdermsci.2018.12.004.
|
| ［30］ |
Ramachandran R, Marino MJ, Paul S, et al. A study and review of effects of botulinum toxins on mast cell dependent and independent pruritus［J］. Toxins （Basel）, 2018,10（4）:134. doi: 10.3390/toxins10040134.
|
